Loading clinical trials...
Loading clinical trials...
Model Informed Precision Dosing of Oral Ibuprofen for Treatment of Persistent Patent Ductus Arteriosus: A Pilot Randomized Controlled Feasibility Trial
Conditions
Interventions
Standard Dose - Ibuprofen oral suspension
Precision Dose - Ibuprofen oral suspension
Locations
1
Canada
McMaster Children's Hospital - Neonatal Intensive Care Unit
Hamilton, Ontario, Canada
Start Date
July 4, 2024
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2027
Last Updated
August 27, 2025
NCT07372495
NCT07015203
NCT07192393
NCT06315556
NCT02997345
NCT07061366
Lead Sponsor
Hamilton Health Sciences Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions